Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Anna M. Nielsen"'
Autor:
Pradere B; Department of Urology UROSUD, La Croix Du Sud Hospital, Quint Fonsegrives, France; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Basile G; Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy., Seisen T; Department of Urology, Pitié-Salpêtrière Hospital, APHP, Sorbonne University, GRC 5, Predictive Onco-Urology, Paris, France. Electronic address: thomas.seisen@aphp.fr.
Publikováno v:
European urology [Eur Urol] 2023 Apr; Vol. 83 (4), pp. e105-e106. Date of Electronic Publication: 2023 Jan 28.
Autor:
Lindgren MS; Department of Urology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: maria.lindgren@dadlnet.dk., Jensen JB; Department of Urology, Aarhus University Hospital, Aarhus, Denmark; Department of Urology, Regional Hospital West Jutland, Holstebro, Denmark; Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.
Publikováno v:
European urology [Eur Urol] 2023 Apr; Vol. 83 (4), pp. e107-e108. Date of Electronic Publication: 2023 Jan 28.
Autor:
Maria S. Lindgren, Jørgen B. Jensen
Publikováno v:
Lindgren, M S & Jensen, J B 2023, ' Reply to Benjamin Pradere, Giuseppe Basile, and Thomas Seisen's Letter to the Editor re : Maria S. Lindgren, Eric Hansen, Nessn Azawi, Anna M. Nielsen, Lars Dyrskjøt, Jørgen B. Jensen. DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial. J Clin Oncol 2023;41:2,206–11 ', European Urology, vol. 83, no. 4, pp. e107-e108 . https://doi.org/10.1016/j.eururo.2023.01.015
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22533b571a98bd22c0caedd4692d23e
https://pure.au.dk/portal/da/publications/reply-to-benjamin-pradere-giuseppe-basile-and-thomas-seisens-letter-to-the-editor-re(c479bc5b-cc7c-4180-a397-3173ba9896c9).html
https://pure.au.dk/portal/da/publications/reply-to-benjamin-pradere-giuseppe-basile-and-thomas-seisens-letter-to-the-editor-re(c479bc5b-cc7c-4180-a397-3173ba9896c9).html
Publikováno v:
European Urology. 83:e105-e106
Autor:
Maria S. Lindgren, Erik Hansen, Nessn Azawi, Anna M. Nielsen, Lars Dyrskjøt, Jørgen B. Jensen
Publikováno v:
Skydt Lindgren, M, Hansen, E B, Azawi, N H, Munk Nielsen, A, Dyrskjøt, L & Jensen, J B 2023, ' DaBlaCa-13 Study: Oncological Outcome of Short-Term, Intensive Chemoresection With Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial ', Journal of Clinical Oncology, vol. 41, no. 2, 41, pp. 206-211 . https://doi.org/10.1200/JCO.22.00470
PURPOSE This study aimed to assess long-term follow-up after chemoresection with mitomycin (MMC), a nonsurgical treatment modality for recurrent nonmuscle invasive bladder cancer (NMIBC). At the time of recurrence, chemoresection has previously been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae14f3fcdac801099e554f706c3f022a
https://pure.au.dk/portal/da/publications/dablaca13-study-oncological-outcome-of-shortterm-intensive-chemoresection-with-mitomycin-in-nonmuscle-invasive-bladder-cancer-primary-outcome-of-a-randomized-controlled-trial(e88f9de7-59e2-4940-b972-938bd9cba8dd).html
https://pure.au.dk/portal/da/publications/dablaca13-study-oncological-outcome-of-shortterm-intensive-chemoresection-with-mitomycin-in-nonmuscle-invasive-bladder-cancer-primary-outcome-of-a-randomized-controlled-trial(e88f9de7-59e2-4940-b972-938bd9cba8dd).html
Autor:
Charlotte S, Voskuilen, Donald, Schweitzer, Jørgen Bjerggaard, Jensen, Anna M, Nielsen, Steven, Joniau, Tim, Muilwijk, Andrea, Necchi, Mounsif, Azizi, Philippe E, Spiess, Alberto, Briganti, Marco, Bandini, Karolien, Goffin, Kirsten, Bouchelouche, Erik, van Werkhoven, Shahrokh F, Shariat, Evanguelos, Xylinas, Nessn H, Azawi, Ja Hyeon, Ku, Beat, Foerster, Bas W G, van Rhijn, Erik, Vegt, Kees, Hendricksen
Publikováno v:
European urology oncology. 3(1)
Presence of lymph node metastases (LNM) is an important prognostic factor for cancer-specific survival (CSS) in patients with upper tract urothelial carcinoma (UTUC). In various neoplasms,To determine the diagnostic value of FDG-PET/CT for LN staging
Autor:
Bertioli, David J.1 david@pos.ucb.br, Moretzsohn, Marcio C.2 marciocm@cenargen.embrapa.br, Madsen, Lene H.3 lhm@mb.au.dk, Sandal, Niels3 nns@mb.au.dk, Leal-Bertioli, Soraya C. M.2 soraya@cenargen.embrapa.br, Guimarães, Patricia M.2 messenbe@cenargen.embrapa.br, Hougaard, Birgit K.3 bm.lisbjerg@mail.tele.dk, Fredslund, Jakob4 jakob.fredslund@alexandra.dk, Schauser, Leif4 schauser@inano.dk, Nielsen, Anna M.3 amn@mb.au.dk, Sato, Shusei5 ssato@kazusa.or.jp, Tabata, Satoshi5 tabata@kazusa.or.jp, Cannon, Steven B.6 steven.cannon@ars.usda.gov, Stougaard, Jens3 stougaard@mb.au.dk
Publikováno v:
BMC Genomics. 2009, Vol. 10, Special section p1-11. 11p. 2 Diagrams, 1 Graph.
Autor:
Stefan Rebenich
Monarchische Herrschaft ist im Altertum omnipräsent. Eine systematische epochen- und kulturvergleichende Untersuchung des Phänomens existiert bislang aber nicht. Der Band schließt diese Lücke. 25 Beiträge, die von ausgewiesenen Spezialisten verf